What We're Reading: Page 208
Industry reads hand-picked by our editors
Dec 20, 2019
-
The Wall Street Journal
Novartis to Offer World’s Most Expensive Drug for Free Via Lottery
-
STAT
Waning treatment is a warning for all 'one-and-done' therapies
-
S&P Global
Lawmakers seek to loosen US FDA drug approval requirements to allow early access
-
C&EN
An oral form of a blockbuster diabetes drug has arrived. Will people be able to get it?
Dec 19, 2019
Dec 18, 2019
Dec 17, 2019
-
The Wall Street Journal
ALS Drug Works in Study, Researchers Say
-
The New York Times
Purdue Pharma Payments to Sackler Family Soared Amid Opioid Crisis
-
POLITICO
Democrats box in Republicans on drug pricing
-
Endpoints News
Inside Astellas' $3B Audentes gene therapy acquisition: coded messages, a bidding war and $77M for the CEO
Dec 16, 2019
Dec 13, 2019
-
C&EN
So you want to make a personalized drug? This company has got your back
-
Bloomberg
Miracle Cancer Drugs Are Making Big Pharma Billions. Others Are Getting Left Behind
-
Endpoints News
Bristol-Myers' strategy, BD chief Paul Biondi exited the company — just ahead of the $74B Celgene deal close
-
Kaiser Health News
In The Fight For Money For The Opioid Crisis, Will The Youngest Victims Be Left Out?
Previous
